|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $113,397,635 | $130,841,582 | $283,353,640 | $258,434,825 | $248,559,229 | $225,148,236 | $206,358,809 |
| Streptomycins & their derivs.; salts thereof | $907,625 | $242,949 | $534,186 | $2,415,762 | $1,321,866 | $318,865 | $1,053,873 |
| Tetracyclines & their derivs.; salts thereof | $658,951 | $1,377,129 | $1,189,577 | $2,393,478 | $1,943,120 | $1,063,704 | $2,310,386 |
| Chloramphenicol & its derivs.; salts thereof | $1,681,375 | $1,624,472 | $1,228,589 | $2,929,739 | $3,442,070 | $2,804,681 | $3,555,905 |
| Erythromycin & its derivs.; salts thereof | $52,470,598 | $50,277,757 | $46,899,043 | $30,500,589 | $57,337,657 | $81,088,894 | $134,144,976 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $121,887,761 | $136,674,070 | $180,248,735 | $301,946,666 | $324,981,560 | $380,495,640 | $535,076,664 |
| Total | $291,003,945 | $321,037,959 | $513,453,770 | $598,621,059 | $637,585,502 | $690,920,020 | $882,500,613 |
|
|
